Why is monocyte purity assessment critical for target validation studies?

Flow cytometry using CD11b, CD115, and F4/80 markers enables quantification of monocyte populations, ensuring that functional readouts reflect monocyte-specific activity rather than macrophage contamination. Purity levels of 45%±12% post-culture and up to 86%±6% after macrophage depletion provide benchmarks for experimental consistency. This supports reliable target engagement measurements in preclinical models.

How does intravenous tail vein injection enable systemic delivery in discovery pipelines?

Intravenous injection of 2.5 million monocytes in saline allows systemic distribution to evaluate monocyte function in models of collateral vessel growth and ischemia. Proper technique—including tail warming, venous access at the distal tail, and slow injection rates—ensures effective delivery without complications like blistering or hemorrhage. This route supports assessment of monocyte-mediated vascular repair in vivo.

What quantitative outputs from flow cytometry enable comparative analysis across experimental conditions?

Flow cytometry provides percentage-positive readouts for CD11b, CD115, and F4/80, allowing researchers to track monocyte purity and maturation over culture timepoints (e.g., increased purity to 90% by day five). These metrics enable side-by-side comparison of culture conditions, depletion strategies, or genetic modifications. Standardized gating based on marker expression supports data reproducibility across teams.

Why do replication requirements matter for cross-functional collaboration in monocyte studies?

Replicating the isolation protocol—including femur/tibia flushing, low-attachment culture, and M-CSF supplementation—ensures consistent monocyte yield and phenotype across laboratories. Variability in bone marrow harvest or culture conditions can affect monocyte-macrophage differentiation, impacting downstream assay reliability. Standardization supports alignment between discovery, screening, and preclinical teams using the same cellular model.

What statistical analysis capabilities are required before implementing monocyte isolation in screening workflows?

Implementing this method in screening requires capability to quantify monocyte purity via flow cytometry and apply statistical tests (e.g., t-tests or ANOVA) to compare conditions across replicates. Thresholds for acceptable purity (e.g., 70% post-depletion) and variability (e.g., ±12%) inform go/no-go decisions for assay robustness. These analyses ensure that monocyte-based assays meet precision standards for hit confirmation and lead optimization.

عزل وحقن في الوريد من الفئران نخاع العظام المستمدة حيدات

23.8K مشاهدات

تم الاستشهاد 31 مرة

09:21 د

ديسمبر 27, 2014

10.3791/52347-v

ديسمبر 27, 2014

23.8K مشاهدات

Martin Wagner¹ , Helen Koester¹ , Christian Deffge¹ , Soenke Weinert¹ , Johannes Lauf¹ , Alexander Francke² , Jerry Lee³ , R. C. Braun- Dullaeus¹ , Joerg Herold¹

¹Department for Cardiology, Angiology and Pneumology, Otto von Guericke University Magdeburg, ²Herzzentrum Dresden, Universitätsklinikum an der Technischen Universität Dresden, Technische Universität Dresden, ³Department of Public Health and Primary Care, University of Cambridge

نقدم هنا بروتوكولا يولد كميات كبيرة من الخلايا الوحيدة الفئران من نخاع العظام غير المتجانسة للتطبيقات الانتقالية. بالمقارنة مع الآخرين ، تساعد هذه الطريقة الجديدة في تقليل عدد المضحية بها وخفض التكاليف عن طريق تجنب الطرق باهظة الثمن مثل فصل الخلايا المغناطيسية عالية التدرج (MACS).